ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
31 Aug 2020 06:29

Shorting Restriction Extension: Prolonged Arb Trade Opportunity on KOSDAQ 150 ETFs

It is now official that Korea's shorting restrictions will get a six-month extension until March 15, 2021.But the KSC is stressing that the...

Logo
289 Views
Share
bullishWuxi Biologics
16 Jul 2020 10:21

Wuxi Biologics - Recap/Learnings from past Placements

Wuxi Biologics (Cayman) Inc (2269 HK) has seen a total of ten placements since listing in Jun 2017. We've covered all of the deals. Given that the...

Logo
481 Views
Share
11 Jul 2020 14:37

Asia Short Interest Weekly - PingAn, WuXi Bio, Meituan, SMIC, Fast Retail, Sumitomo, Yageo, Genius

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
321 Views
Share
06 Jul 2020 19:30

Celltrion Healthcare: Block Deal Sale by One Equity Partners (Time to Turn Bearish)

It was announced after the market close today that One Equity Partners will sell 3.15 million shares of Celltrion Healthcare (091990 KS) shares in...

Logo
315 Views
Share
06 Jul 2020 16:40

Celltrion Healthcare Placement: Clean up Trade for One Equity Partner

One Equity Partners is looking to sell 3.16 m shares in Celltrion Healthcare (091990 KS). This is a clean up trade by the shareholder and happens...

Logo
288 Views
Share
x